يعرض 1 - 20 نتائج من 52 نتيجة بحث عن '"Vergote, I. B."', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Conference

    المصدر: Colombo , N , Gadducci , A , Sehouli , J , Biagioli , E , Nyvang , G-B , Riniker , S , Montes , A , Ottevanger , N , Zeimet , A G G , Vergote , I B , Funari , G , Baldoni , A , Tognon , G , De Censi , A , Churruca Galaz , C , Chekerov , R , Maenpaa , J , Rulli , E , Fossati , R & Poveda , A 2020 , ' INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum ....

  2. 2
    Academic Journal

    المصدر: FACTS, VIEWS & VISION IN OBGYN ; ISSN: 2032-0418 ; ISSN: 2684-4230

    وصف الملف: application/pdf

  3. 3
    Conference

    المصدر: Lecuru , F , Sehouli , J , Vergote , I B , Reuss , A , Classe , J-M , Hillemanns , P , Greggi , S , Mirza , M R , Brachet , P E , Follana , P , Raban , N , Hasenburg , A , Zang , R , Lindemann , K , Kim , J-W , Poveda , A , Raspagliesi , F , Haslund , C A , du Bois , A & Harter , P 2022 , ' Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trial ' ....

  4. 4
    Academic Journal

    المصدر: Concin , N , Vergote , I B , Lassen , U N , Drew , Y , Machiels , J P , Arkenau , H T , Forster , M D , Jones , R , Johnson , M L , Slomovitz , B M , Spicer , J , Cornez , N , Gennigens , C , Coleman , R L , Windfeld , K , Ghatta , S , Rangwala , R A & Hong , D S 2018 , ' A phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic ....

  5. 5
    Report

    المساهمون: Saitama Medical School ,, 3387600

    Relation: Fujiwara K., Vergote I. B. , Sehouli J., Salutari V., Zola P., Madry R., Wenham R. M. , Korach J., Pautier P., Cibula D., et al., "ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA(sic)-nonmutated advanced epithelial ovarian cancer", European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapur, 22 - 24 Kasım 2019, cilt.30; av_868a78fc-884c-45c8-9d78-047ab3dc2377; vv_1032021; http://hdl.handle.net/20.500.12627/178802; 30

  6. 6
  7. 7
    Conference

    المصدر: Gonzalez Martin , A , Pothuri , B , Vergote , I B , Christensen , R D , Graybill , W , Mirza , M R , McCormick , C , Lorusso , D , Hoskins , P , Freyer , G , Backes , F , Baumann , K , Redondo , A , Moore , R G , Vulsteke , C , O'Cearbhaill , R E , Lund , B , Li , Y , Gupta , D & Monk , B J 2019 , ' Niraparib therapy in patients with newly diagnosed advanced ovarian cancer ....

  8. 8
    Academic Journal

    المصدر: Vergote , I B , Lund , B , Peen , U , Umajuridze , Z , Mau-Sorensen , M , Kranich , A , Van Nieuwenhuysen , E , Haslund , C , Nottrup , T , Han , S N , Concin , N , Unger , T J , Chai , Y , Au , N , Rashal , T , Joshi , A , Crochiere , M , Landesman , Y , Shah , J , Shacham , S , Kauffman , M & Mirza , M R 2020 , ' Phase 2 study of ....

    مصطلحات موضوعية: Cervical cancer, Endometrial cancer, Ovarian cancer, Selinexor, XPO1

  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المساهمون: Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, I. B., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V., Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, M. C., Gallo, C., Perrone, F.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/28825853; info:eu-repo/semantics/altIdentifier/wos/WOS:000412454000012; volume:35; issue:29; firstpage:3347; lastpage:3353; numberofpages:7; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11586/250804; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85031899498

  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Book
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المصدر: International Journal of Gynecological Cancer ; volume 7, issue 5, page 368-375 ; ISSN 1048-891X 1525-1438